BioSpace News Archive

Allurion Technologies announced today two major milestones with the launch of the transformed Allurion Weight Loss Program and new worldwide brand for the company and its program.

Combination of tipifarnib and alpelisib shows robust activity in preclinical PDX models of HRAS and PIK3CA pathway dependent tumors.

Braxia Scientific Corp. is pleased to announce its participation at the upcoming PSYCH Investor Summit: Research & Development conference on July 7, 2021.

The Pancreatic Cancer Action Network (PanCAN), a leading nonprofit in the fight against pancreatic cancer, has appointed Marco Argenti, co-chief information officer of Goldman Sachs, and Karyn Temple, senior executive vice president and global general counsel for the Motion Picture Association to its board of directors.

There are possibilities that an athlete might suffer detachment of a ligament or tendon and/or any other soft tissue in the body while practicing or during the game.

Development of assays that feature as rapid medical diagnostics attracts groundswell of interest of healthcare systems worldwide.

Catalyst Biosciences, Inc. announced four poster presentations on marzaptacog alfa and dalcinanonog alfa at the upcoming International Society on Thrombosis and Haemostatis Virtual Congress being held from July 17-21, 2021.

BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced that Christopher von Jako, Ph.D., President and Chief Executive Officer, will present at the Ladenburg Thalmann 2021 Healthcare Conference on July 14, 2021.

Amolyt Pharma, a global company specializing in developing therapeutic peptides for rare endocrine and related diseases, today announced that the company has hired biotechnology senior executive Louis J. Arcudi III as chief financial officer.

Uro Medical Corporation announced the acquisition of Micron Medical Corporation’s urology-based assets, including the continuation of the Protect randomized controlled trial, which is a head to head study comparing tibial stimulation to sacral stimulation.